The Challenges in Biomarker Testing in Gastroesophageal Cancer / cancer, esmo 2026, ESMO 26, gastroesophageal cancer, Maria Maddalena ...
Does Immunotherapy Have a Role in HR+/HER2− Metastatic Breast Cancer? / Breast Cancer, cancer, esmo 2026, ESMO 26, ...
Beyond Science, It’s the People Who Make ESMO Special / Amalya Sargsyan, Arpi Asminian, cancer, Emad Shash, ESMO, esmo 2026, ...
What Should Oncologists Know About mRNA Cancer Vaccines? / cancer, cancer vaccines, ESMO, esmo 2026, ESMO 26, Menna Fouda, OncoDaily, Oncology ...
At the Community Oncology Global Congress (COGC 2026), organized by OncoDaily, Amol Akhade, Senior Consultant in Medical ...
CROWN ctDNA data link early lorlatinib progression to genomic complexity, TP53 and bypass pathways rather than new ALK ...
SHR-A2102 at ESMO 2026 Shows 47.2% Response Rate in Recurrent or Metastatic Cervical Cancer / cancer, ESMO, esmo 2026, ...
VIKTORIA-1 shows gedatolisib maintained strong PFS benefit over alpelisib in PIK3CA-mutant HR+/HER2− breast cancer, including ...
HBI-8000-303 evaluates the HDAC inhibitor HBI-8000 plus nivolumab in advanced melanoma, examining PFS, response, safety, and ...
Mongolia’s Former Minister of Health Dr Chinburen Jigjidsuren Will Join the International Advisory Board of Dr Gevorg ...
Celebrating 8 Community Members Elected to the National Academy of Medicine - The Mark Foundation for Cancer Research / ...
Daraxonrasib Versus Chemotherapy in Metastatic Pancreatic Cancer – Additional Subgroup Analyses / cancer, cancer care, Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results